Fundamental Data for MDT

MEDTRONIC(NYSE:MDT)

Medtronic is the world''s leading medical technology company, pioneeringdevice-based therapies that restore health, extend life and alleviate pain.Primary products include those for bradycardia pacing, tachyarrhythmiamanagement, atrial fibrillation management, among others. Medtronic operates its business in one reportable segment, that of manufacturing and selling device-based medical therapies. The company does business in more than 120 countries. The company''s product lines include cardiac rhythm management, neurological and spinal, vascular and cardiac surgery.

# Employees: 41000

Address: 710 Medtronic Parkway,Minneapolis,MN,USA

Phone: 763 514-4000

Fax: 763 514-4879

Website: www.medtronic.com

Email: investor.relations@medtronic.com

Sector: Medical

Industry: MED PRODUCTS

Executive Officers

William A. Hawkins (Pres.; C.O.O.)

Gary L. Ellis (Sr. V.P.; C.F.O.)

Richard H. Anderson (Dir.)

David L. Calhoun (Dir.)

Arthur D. Collins Jr. (Dir.,)

Dividend

Ex-Dividend Date: 10/7/2009

Annual Dividend: $0.82

Current Dividend Yield: $2.07

Dividend Paid (3 months): $0.20

Indicated Dividend: N/A

Earnings

Last Earnings Date: 7/31/2009

Next Earnings Date(Expected): 11/24/2009

Mean EPS (Next Qtr): $0.75

Mean EPS (Year): $3.15

Mean Estimate(Long Term): $10.68

P/E Ratio(Based on EPS estimate): 12.570

Number of Estimates: 30

Shares Performance

Period	MDT	Compare to S&P
YTD	26.10 %	4.36 %
4 Weeks	8.94 %	7.76 %
12 Weeks	2.46 %	-3.41 %

Shares Information

Analyst Coverage: Y

Avg Volume: 5700301

Shares Outstanding: 1106M

Market Cap: $43.85B

52 Week High: $40.20

52 Week Low: $24.38

P/E Ratio: 13.250

PEG Ratio: 1.180

Split: On 9/27/1999 MDT split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: -3.66 %

EPS Growth in Last Year: 9.72 %

Sales Growth in Last Quarter: 2.72 %

Sales Growth in Last Quarter: 6.13 %

Financials

Qtr Book Value: $3.35

Cash Flow/Share: $11.14

Change in Payout Ratio: -0.010

Price/Sales: -0.010